RecruitingNot ApplicableNCT03017118

Turmeric for Patients With Basal Joint Arthritis

A Randomized Controlled Trial Using Turmeric for Patients With Basal Joint Arthritis


Sponsor

Massachusetts General Hospital

Enrollment

60 participants

Start Date

Aug 9, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and Turmeric for people with thumb osteoarthritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTTurmeric

Subjects will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.

OTHERPlacebo

Subjects in the control group will receive a placebo 3 times per day for 6 weeks.


Locations(1)

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03017118


Related Trials